EMSF vs. ARKG ETF Comparison
Comparison of Matthews Emerging Markets Sustainable Future Active ETF (EMSF) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
EMSF
Matthews Emerging Markets Sustainable Future Active ETF
EMSF Description
EMSF actively invests in common and preferred stocks of companies in emerging markets, including countries that may be considered frontier. While the fund has an all-cap exposure, it expects to invest substantially in smaller companies. The fund looks for sustainable growth based on fundamental characteristics such as balance sheet information, size, cash flow stability, and financial health. It also applies various ESG standards, using third-party data and the adviser's proprietary research, to identify investments that potentially contribute to a sustainable future by addressing global environmental and social challenges. The fund also employs exclusionary ESG screens, which avoid controversial businesses such as tobacco, weapons, and fossil fuels. The fund may engage its portfolio companies on sustainability and governance matters through active dialogue, exercising shareholder rights, and encouraging enhanced ESG disclosure.
Grade (RS Rating)
Last Trade
$27.03
Average Daily Volume
2,753
6
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$24.00
Average Daily Volume
1,832,233
34
Performance
| Period | EMSF | ARKG |
|---|---|---|
| 30 Days | -7.39% | -3.38% |
| 60 Days | 3.44% | -9.06% |
| 90 Days | 9.12% | -2.52% |
| 12 Months | 10.28% | -1.36% |
0 Overlapping Holdings
| Symbol | Grade | Weight in EMSF | Weight in ARKG | Overlap |
|---|
EMSF Underweight 34 Positions Relative to ARKG
| Symbol | Grade | Weight | |
|---|---|---|---|
| TWST | F | -8.58% | |
| CRSP | C | -7.19% | |
| RXRX | F | -7.13% | |
| CDNA | D | -5.09% | |
| VCYT | A | -4.56% | |
| IONS | F | -4.4% | |
| ADPT | A | -4.37% | |
| NRIX | B | -4.29% | |
| NTLA | F | -3.81% | |
| NTRA | B | -3.75% | |
| TXG | F | -3.63% | |
| SDGR | F | -3.51% | |
| BEAM | F | -3.46% | |
| ARCT | F | -3.22% | |
| PSNL | C | -2.91% | |
| GH | D | -2.64% | |
| ABSI | D | -2.43% | |
| VEEV | B | -2.13% | |
| PACB | C | -2.11% | |
| AMGN | C | -1.94% | |
| VRTX | D | -1.56% | |
| ACCD | F | -1.42% | |
| BFLY | A | -1.32% | |
| EXAS | A | -1.26% | |
| INCY | A | -1.25% | |
| CERS | F | -1.12% | |
| REGN | F | -1.12% | |
| MRNA | F | -1.08% | |
| CMPS | F | -1.0% | |
| PRME | C | -0.92% | |
| MASS | F | -0.86% | |
| QSI | F | -0.73% | |
| RPTX | C | -0.72% | |
| ILMN | A | -0.26% |
EMSF: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords
Compare ETFs
